Mesoblast (MESO) EBITDA Margin Growth (1y) (2017 - 2023)
Mesoblast (MESO) EBITDA Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 632,264.00 |
| Mar 31, 2023 | -13,871.00 |
| Dec 31, 2022 | 37,148.00 |
| Sep 30, 2022 | 20,186.00 |
| Jun 30, 2022 | -375,908.00 |
| Mar 31, 2022 | 237,179.00 |
| Dec 31, 2021 | 182,592.00 |
| Sep 30, 2021 | 292,575.00 |
| Jun 30, 2021 | -29,812.00 |
| Mar 31, 2021 | -53,256.00 |
| Dec 31, 2020 | 28,807.00 |
| Sep 30, 2020 | -236,423.00 |
| Jun 30, 2020 | 132,211.00 |
| Mar 31, 2020 | 188,216.00 |
| Dec 31, 2019 | 96,849.00 |
| Sep 30, 2019 | -139,821.00 |
| Jun 30, 2019 | -2,088.00 |
| Mar 31, 2019 | -35,232.00 |
| Dec 31, 2018 | -229,801.00 |
| Sep 30, 2018 | 244,826.00 |